Opportunity Information: Apply for PAR 16 014
Apply for PAR 16 014
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Novel Genomic Technology Development (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172,.
- This funding opportunity was created on Oct 27, 2015 and posted on Oct 27, 2015.
- Applicants must submit their applications by Jan 11, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $700,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Novel Genomic Technology Development (R01) opportunity, published by HHS/NIH (agency listing HHS-NIH11) under Funding Opportunity Number PAR-16-014, is a discretionary grant program in the health research area (CFDA 93.172). Its core purpose is to spark major leaps forward in genomics by funding the development of new technologies, with an explicit emphasis on areas beyond standard nucleic acid sequencing platform development. In other words, it is aimed at enabling tools, methods, and technological capabilities that can meaningfully change what researchers can measure, build, or infer in genomics, rather than simply producing another sequencing instrument or incremental sequencing improvement.
The program is framed around “very novel and high impact†technology development, meaning NIH is signaling strong interest in ideas that are genuinely new, potentially high-risk, and capable of reshaping genomics research. The FOA’s horizon for impact is also clearly stated: the supported technologies should be positioned to make a major difference within roughly five to seven years. That timeline suggests the work should go beyond a purely speculative concept, but it can still be early-stage as long as the project plan plausibly leads to a transformative capability on a reasonable development path.
The funding mechanism is the R01, which is NIH’s standard research project grant format and is typically used for multi-year, hypothesis-driven or technology-driven projects with a defined scope of work, milestones, and deliverables. The opportunity lists an award ceiling of $700,000, indicating the maximum award amount expected under this announcement (as presented in the source data). The posting and creation dates are October 27, 2015, and the listed closing date for applications is January 11, 2018 (both the original and current closing dates match in the provided record). The entry also notes “ExpectedAwards:†without a number supplied in the source data, so the anticipated count of funded projects is not specified in what you shared.
Eligibility is broad and designed to capture a wide range of organizations capable of developing impactful genomics technologies. Eligible applicants include multiple levels of government (state, county, and city/township), special district governments, independent school districts, and tribal governments (federally recognized), as well as tribal organizations that are not federally recognized. Academic participation is strongly accommodated: public/state-controlled institutions of higher education and private institutions of higher education are eligible. The FOA also welcomes nonprofit organizations both with and without 501(c)(3) status (so long as they are not institutions of higher education in those categories), and it allows for-profit organizations (other than small businesses) as well as small businesses. There is also an “Others (see text field entitled Additional Information on Eligibility for clarification)†category, which typically means the full FOA may include additional eligible entities or conditions not captured in the abbreviated listing.
In practical terms, this announcement is best read as NIH setting aside a lane for ambitious genomics-enabling technology projects that could unlock new kinds of biological questions, improve the resolution or scale of genomic measurements, integrate genomic data with other modalities, or otherwise change the state of the art in how genomics is done, analyzed, or applied. The central message is that NIH is looking for technology development that is innovative enough to be field-shaping, with credible development plans and a realistic path to broad scientific impact within the next several years, while intentionally not focusing on the continued evolution of sequencing machines themselves.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is called Novel Genomic Technology Development (R01).
Which agency is offering this funding?
This funding opportunity is published by HHS/NIH (agency listing HHS-NIH11).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PAR-16-014.
What type of grant mechanism is being used?
The mechanism is an R01, which is NIH's standard research project grant format used for multi-year projects with a defined scope of work, milestones, and deliverables. The description indicates it can support technology-driven projects (not only traditional hypothesis-driven studies), as long as the plan is credible and outcome-focused.
What program area does this funding fall under?
It is a discretionary grant program in the health research area.
What is the CFDA number listed for this opportunity?
The listing identifies CFDA 93.172.
What is the main purpose of this funding opportunity?
The core purpose is to spark major leaps forward in genomics by funding the development of new technologies. The emphasis is on enabling tools, methods, and technological capabilities that can meaningfully change what researchers can measure, build, or infer in genomics.
Is this opportunity intended to fund new DNA/RNA sequencing platforms?
No. The announcement explicitly emphasizes areas beyond standard nucleic acid sequencing platform development. In other words, it is not aimed at producing another sequencing instrument or incremental sequencing improvements.
What kind of projects does NIH appear to be most interested in under this FOA?
The framing is for "very novel and high impact" technology development. Based on the provided description, NIH is signaling strong interest in ideas that are genuinely new, potentially high-risk, and capable of reshaping genomics research.
How soon should the proposed technology be expected to make a meaningful difference?
The FOA states an impact horizon of roughly five to seven years. That suggests the project can be early-stage, but it should not be purely speculative; the plan should plausibly lead to a transformative capability on a realistic development path.
What is the maximum award amount (award ceiling) shown in the provided record?
The opportunity lists an award ceiling of $700,000, meaning the maximum award amount expected under this announcement as presented in the source data.
How many awards does NIH expect to make?
The provided record shows "ExpectedAwards:" but does not supply a number. Based on the information provided only, the anticipated count of funded projects is not specified.
When was this opportunity posted and created?
The posting and creation dates are both listed as October 27, 2015.
What is the application closing date?
The listed closing date for applications is January 11, 2018. The record notes that the original and current closing dates match (based on what was provided).
Who is eligible to apply?
Eligibility is described as broad. Eligible applicants include:
- Government entities: state, county, and city/township governments
- Special district governments
- Independent school districts
- Tribal governments (federally recognized)
- Tribal organizations (not federally recognized)
- Institutions of higher education: public/state-controlled and private
- Nonprofits: with and without 501(c)(3) status (in the categories specified as not institutions of higher education)
- For-profit organizations (other than small businesses)
- Small businesses
- Others (as referenced by the category that points to additional eligibility clarification in the full FOA text)
Are for-profit organizations eligible?
Yes. The eligibility list explicitly includes for-profit organizations (other than small businesses) and also separately includes small businesses.
Are nonprofit organizations eligible even if they do not have 501(c)(3) status?
Yes. The eligibility list includes nonprofit organizations with and without 501(c)(3) status (within the categories described in the provided record).
Are academic institutions eligible?
Yes. Both public/state-controlled institutions of higher education and private institutions of higher education are listed as eligible.
Are tribal entities eligible?
Yes. The eligibility list includes tribal governments (federally recognized) and also includes tribal organizations that are not federally recognized.
What does the "Others" eligibility category mean?
The listing includes an "Others (see text field entitled Additional Information on Eligibility for clarification)" category. Based on the information provided only, this indicates the full FOA may include additional eligible entities or conditions not captured in the abbreviated listing.
What is the focus of the technology development being encouraged?
The opportunity is positioned as a lane for ambitious genomics-enabling technologies that could unlock new kinds of biological questions, improve the resolution or scale of genomic measurements, integrate genomic data with other modalities, or otherwise change the state of the art in how genomics is done, analyzed, or applied.
Does the FOA encourage high-risk, high-reward ideas?
Yes. The description emphasizes very novel and high impact technologies, and it explicitly notes that NIH is signaling interest in concepts that are genuinely new and may be high-risk, as long as there is a credible development plan and a plausible path to field-level impact.
What is the key message applicants should take from this announcement?
The central message is that NIH is looking for field-shaping, innovative technology development in genomics, with credible milestones and a realistic path to broad scientific impact within the next several years, while intentionally not focusing on continued evolution of sequencing machines themselves.
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Health
Next opportunity: Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in National Disasters Declared by the President
Previous opportunity: Collection and Compilation of Water Pipeline Field Performance Data
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 014
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 014) also looked into and applied for these:
| Funding Opportunity |
|---|
| Nurse Education, Practice, Quality and Retention – Bachelor of Science in Nursing Practicums in Community Settings Program Apply for HRSA 16 066 Funding Number: HRSA 16 066 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reinforcing HIV Clinical Services within a Network of Public Health Institutions in the Central Plateau and the Lower Artibonite of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1712 Funding Number: CDC RFA GH16 1712 Agency: HHS-CDC-CGH Category: Health Funding Amount: $7,500,000 |
| International Centers of Excellence for Malaria Research (U19) Apply for RFA AI 15 056 Funding Number: RFA AI 15 056 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Strengthening Epidemiology and Strategic Information in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1675 Funding Number: CDC RFA GH16 1675 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,010,000 |
| NHLBI Progenitor Cell Translational Consortium Coordinating Center (U24) Apply for RFA HL 16 022 Funding Number: RFA HL 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Foundational Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) Apply for RFA RM 15 020 Funding Number: RFA RM 15 020 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Service Area Competition Apply for HRSA 16 008 Funding Number: HRSA 16 008 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Protecting the Advances in Polio, Rubella and Measles Elimination: Strengthening Immunization Programs in the Americas. Apply for CDC RFA GH14 140103CONT16 Funding Number: CDC RFA GH14 140103CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| USAID Regional Health Integration to Enhance Services in East Central Uganda (USAID RHITES EC) Apply for RFA 617 16 000001 Funding Number: RFA 617 16 000001 Agency: USAID-UGA Category: Health Funding Amount: $57,000,000 |
| Technical Assistance in Support of HIV Prevention, Care, and Treatment Programs and Other Infectious Diseases that Impact HIV Infected Patients in Support of the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS09 904SUPP Funding Number: CDC RFA PS09 904SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rural Health Network Development Planning Program Apply for HRSA 16 017 Funding Number: HRSA 16 017 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| MCH Navigator Program Apply for HRSA 16 043 Funding Number: HRSA 16 043 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting and Maintaining the Surveillance System for Chronic Kidney Disease in the United States Apply for CDC RFA DP16 1604 Funding Number: CDC RFA DP16 1604 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $700,000 |
| Local Non-governmental Partnerships for Sustained Country Leadership in Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 141202CONT16 Funding Number: CDC RFA GH14 141202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Development and Translation of Medical Technologies to Reduce Health Disparities (SBIR) (R43/R44) Apply for RFA EB 16 001 Funding Number: RFA EB 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Integrated HIV Prevention Program for the Federal Police Force of Ethiopia Under the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10110SUPP Funding Number: CDC RFA PS10 10110SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| COMPREHENSIVE PLATFORM FOR INTEGRATED COMMUNICATIONS INITIATIVE (CPICI) Apply for RFI 621 16 00002 Funding Number: RFI 621 16 00002 Agency: USAID-TAN Category: Health Funding Amount: $46,200,000 |
| NIDCD Early Career Research (ECR) Award (R21) Apply for PAR 16 057 Funding Number: PAR 16 057 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Tropical Medicine Research Centers (U19) Apply for RFA AI 16 002 Funding Number: RFA AI 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Improving the Quality of HIV Service Delivery and Other Priority Public Health Interventions through Training Support for Epidemiology, Monitoring and Evaluation (M&E), Survey and Laboratory Services in Nigeria under the President’s Emergency Plan Apply for CDC RFA GH16 1642 Funding Number: CDC RFA GH16 1642 Agency: HHS-CDC-CGH Category: Health Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 014", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.